Author

Kathrin Laue

Tel Aviv UniversityORCID 0009-0005-7132-6862Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Ron Saad· 2 shared Tom WinkleriD· 2 shared Uri Ben‐DavidiD· 2 shared Alessandra RustighiiD· 1 shared Alessia Andrea RicciiD· 1 shared Alexander S. BrandisiD· 1 shared Alexander Schäffer· 1 shared Alicia I. Leikin-FrenkeliD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ron Saad

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature GeneticsPeer-reviewedDec 29, 2025

Inactivation of p53 drives breast cancer brain metastasis by altering fatty acid metabolism

Kathrin Laue, Sabina Pozzi, Johanna Zerbib…·Uri Ben‐David

This study shows that p53 inactivation promotes breast cancer brain metastasis by altering fatty acid metabolism, with implications for therapeutic targeting.

24 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 2, 2025

Chromosome-arm 17p Loss Renders Breast Cancer Cells Vulnerable to AURKB Inhibition

Tom Winkler, Eran Sdeor, Ron Saad…·Uri Ben‐David

This study identifies Del17p as a biomarker for AURKB inhibition in breast cancer, showing increased sensitivity to AURKB inhibitors in Del17p tumors.

DOI 10.64898/2025.12.01.691489

humanbulk RNA-seq

𝕏 PostBluesky